Middeldorp S - Search Results

1

Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors.

Milling TJ Jr, Middeldorp S, Xu L, Koch B, Demchuk A, Eikelboom JW, Verhamme P, Cohen AT, Beyer-Westendorf J, Gibson CM, Lopez-Sendon J, Crowther M, Shoamanesh A, Coppens M, Schmidt J, Albaladejo P, Connolly SJ; ANNEXA-4 Investigators. Milling TJ Jr, et al. Among authors: middeldorp s. Circulation. 2023 Mar 28;147(13):1026-1038. doi: 10.1161/CIRCULATIONAHA.121.057844. Epub 2023 Feb 20. Circulation. 2023. PMID: 36802876 Free article. Clinical Trial.

2

The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.

Middeldorp S, Henkens CM, Koopman MM, van Pampus EC, Hamulyák K, van der Meer J, Prins MH, Büller HR. Middeldorp S, et al. Ann Intern Med. 1998 Jan 1;128(1):15-20. doi: 10.7326/0003-4819-128-1-199801010-00003. Ann Intern Med. 1998. PMID: 9424976

3

Oral contraceptives and hormonal replacement therapy cause an imbalance in coagulation and fibrinolysis which may explain the increased risk of venous thromboembolism.

Levi M, Middeldorp S, Büller HR. Levi M, et al. Among authors: middeldorp s. Cardiovasc Res. 1999 Jan;41(1):21-4. doi: 10.1016/s0008-6363(98)00210-7. Cardiovasc Res. 1999. PMID: 10325950 No abstract available.

4

Monitoring therapy with vitamin K antagonists in patients with lupus anticoagulant: effect on different tests for INR determination.

Bijsterveld NR, Middeldorp S, Berends F, Büller HR. Bijsterveld NR, et al. Among authors: middeldorp s. J Thromb Thrombolysis. 2000 Apr;9(3):263-9. doi: 10.1023/a:1018722829498. J Thromb Thrombolysis. 2000. PMID: 10728026

5

Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.

Middeldorp S, Meijers JC, van den Ende AE, van Enk A, Bouma BN, Tans G, Rosing J, Prins MH, Büller HR. Middeldorp S, et al. Thromb Haemost. 2000 Jul;84(1):4-8. Thromb Haemost. 2000. PMID: 10928461 Clinical Trial.

6

Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.

Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN. Meijers JC, et al. Among authors: middeldorp s. Thromb Haemost. 2000 Jul;84(1):9-14. Thromb Haemost. 2000. PMID: 10928462 Clinical Trial.

7

A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.

Tans G, Curvers J, Middeldorp S, Thomassen MC, Meijers JC, Prins MH, Bouma BN, Büller HR, Rosing J. Tans G, et al. Among authors: middeldorp s. Thromb Haemost. 2000 Jul;84(1):15-21. Thromb Haemost. 2000. PMID: 10928463 Clinical Trial.

8

How to decide on the optimal duration of anticoagulatn therapy in carriers of the factor V Leiden mutation.

Middeldorp S, Büller HR. Middeldorp S, et al. Thromb Haemost. 2000 Nov;84(5):740-1. Thromb Haemost. 2000. PMID: 11127847 No abstract available.

9

[Effects of second and third generation oral contraceptives on hemostasis].

Middeldorp S, Rosing J, Bouma BN, Büller HR. Middeldorp S, et al. Ned Tijdschr Geneeskd. 2001 Feb 10;145(6):252-6. Ned Tijdschr Geneeskd. 2001. PMID: 11236370 Review. Dutch.

10

The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden.

Middeldorp S, Libourel EJ, Hamulyák K, Van der Meer J, Büller HR. Middeldorp S, et al. Br J Haematol. 2001 May;113(2):553-5. doi: 10.1046/j.1365-2141.2001.02766.x. Br J Haematol. 2001. PMID: 11380431 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

458 results

Search Page